US equities |
INTC $64.47 ▼-29.97% AMZN $238.99 ▼-1.97% MU $881.00 ▼-5.70% NVDA $204.91 ▼-4.10% SNDK $1,169.41 ▼-12.08% GOOGL $281.53 ▼-0.81% SPCX $138.22 ▼-3.94% AMD $505.76 ▼-10.71%
FinancialContent

Latest News about Diabetic Macular Edema

Recent news which mentions Diabetic Macular Edema

FDA Approves First Injectable Eye Medicine For Vision Loss Disorder - Genentech's Vabysmo
Tickers RHHBF RHHBY RHHVF
Tags RHHBF Diabetic Macular Edema Age/Related Macular Degeneration
From Benzinga
Novartis Reveals Two Year Results From Beovu Trial In Diabetic Macular Edema Patients
Tickers NVS REGN
Tags REGN NVS Market News
From Benzinga
Why Did Mizuho Upgrade This Biotech Stock Focused On Age-Related Eye Diseases?
Tickers UBX
Tags Trading Ideas Long Ideas News
From Benzinga
Unity Biotechnology Stock Falls After Updated Data From Wet AMD Candidate
Tickers UBX
Tags Penny Stocks Age/Related Macular Degeneration General
From Benzinga
Novartis Shares Two Year Beovu Data From Diabetic Macular Edema Studies
Tickers NVS REGN
Tags General Diabetic Macular Edema Biotech
From Benzinga
Adverum Stock Falls As It Stops Testing Ocular Gene Therapy Candidate In Diabetic Macular Edema Patients
Tickers ADVM
Tags General Penny Stocks Diabetic Macular Edema
From Benzinga